Groundbreaking Progress in Gene Therapy and Stem Cell Treatments for Retinitis Pigmentosa
The field of Retinitis Pigmentosa (RP) treatment is currently experiencing rapid, breakthrough advancements centered on addressing the root genetic causes and the consequences of photoreceptor cell death. While the first FDA-approved gene therapy,